Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Arcturus Therapeutics Holdings Inc. (ARCT)

41.05   0.96 (2.39%) 09-29 00:46
Open: 40.47 Pre. Close: 40.09
High: 41.15 Low: 38.59
Volume: 430,642 Market Cap: 1,001M
Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. The company is headquartered in San Diego, California and currently employs 72 full-time employees. The firm owns Lipid-enabled and Unlocked Nucleomonomer Agent modified RNA (LUNAR) lipid-mediated delivery and Unlocked Nucleomonomer Agent (UNA) technology, including UNA Oligomers. The Company’s diverse pipeline of RNA therapeutics includes programs pursuing rare diseases, Hepatitis B, non-alcoholic steatohepatitis (NASH), cystic fibrosis and vaccines. The Company’s versatile RNA therapeutics platforms can be applied toward multiple types of RNA medicines, including small interfering RNA, messenger RNA, replicon RNA, antisense RNA, microRNA and gene editing therapeutics. The firm's UNA technology can be used to target individual genes in the human genome, as well as viral genes, and other species for therapeutic purposes.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 41.188 - 41.347 41.347 - 41.529
Low: 38.176 - 38.339 38.339 - 38.527
Close: 40.73 - 41.006 41.006 - 41.324

Technical analysis

as of: 2020-09-28 4:29:54 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 61.77     One year: 74.99
Support: Support1: 34.59    Support2: 28.78
Resistance: Resistance1: 52.89    Resistance2: 64.20
Pivot: 41.14
Moving Average: MA(5): 39.74     MA(20): 41.28
MA(100): 46.95     MA(250): 26.87
MACD: MACD(12,26): -2.53     Signal(9): -2.65
Stochastic oscillator: %K(14,3): 37.28     %D(3): 34.77
RSI: RSI(14): 44.52
52-week: High: 66.24  Low: 8.51  Change(%): 332.1
Average Vol(K): 3-Month: 78400  10-Days: 83383

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ARCT has closed above bottom band by 49.1%. Bollinger Bands are 50.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to ARCT's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 24 Sep 2020
Analyst Rating: Will Arcturus Therapeutics Holdings Inc (ARCT) Stock Outperform the Market? - InvestorsObserver

Mon, 21 Sep 2020
Is Arcturus Therapeutics Holdings Inc.’s (NASDAQ:ARCT) Shareholder Ownership Skewed Towards Insiders? - Simply Wall St

Mon, 21 Sep 2020
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Recent Earnings Shows Major Promise - The Oracle Dispatch

Mon, 21 Sep 2020
Roll up the Sleeves! When the bell rang at previous close Arcturus Therapeutics Holdings Inc. (ARCT) was up 2.99% - The InvestChronicle

Sat, 19 Sep 2020
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Expected to Announce Quarterly Sales of $3.17 Million - MarketBeat

Tue, 08 Sep 2020
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 24
Shares Float (M) 17
% Held by Insiders 29.93
% Held by Institutions 30.92
Shares Short (K) 1,540
Shares Short P. Month (K) 1,650

Stock Financials

EPS -2.520
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 4.530
Profit Margin
Operating Margin -358.42
Return on Assets (ttm) -22.8
Return on Equity (ttm) -66.9
Qtrly Rev. Growth -77.1
Gross Profit (p.s.) -0.527
Sales Per Share 0.461
EBITDA (p.s.) -1.624
Qtrly Earnings Growth
Operating Cash Flow (M) -31
Levered Free Cash Flow (M) -15

Stock Valuations

PE Ratio -16.29
PEG Ratio
Price to Book value 9.06
Price to Sales 89.00
Price to Cash Flow -32.58

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.